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املضاعفات الكبدية - الصفراوية عند األطفال املصابني مبرض فقر الدم املنجلي 
مبستشفى الوحدة التعليمي يف عدن باليمن
حنان علوي غالب و جمال ح�سني زين
abstract: Objectives: This study aimed to describe the pattern of hepatobiliary complications among patients 
with sickle cell disease (SCD) and to assess their correlation with age, gender and other risk factors. Methods: This 
cross-sectional study assessed 106 patients with SCD who were admitted to Al Wahda Teaching Hospital in Aden, 
Yemen, between January and June 2009. A full history, thorough examination, essential laboratory investigations 
(including a complete blood count, liver function test and viral markers test) and an abdominal ultrasound were 
performed on all patients. The clinicopathological characteristics of the hepatobiliary complications were analysed 
for their correlation to different risk factors such as age and gender. Results: It was found that 46.2% of the patients 
with SCD had hepatobiliary complications. Of these, 36.7% had viral hepatitis, 26.0% had cholecystitis and 20% 
had gallstones. A total of 60.4% of the affected patients were male. The mean levels of alanine aminotransferase 
(59.4 and 56.0 U/L) and aspartate transaminase (40.1 and 38.3 U/L) were significantly elevated in patients with 
viral hepatitis and cholecystitis, respectively. Hepatitis B virus surface antigen showed higher positivity (10.4%) 
than anti-hepatitis A and anti-hepatitis C antibodies. Hepatobiliary complications increased significantly with 
age and were notably higher among those who were often admitted to hospital and/or underwent frequent blood 
transfusions. Conclusion: This study suggests that hepatobiliary complications are common among SCD patients 
and the likelihood of developing such complications increases as patients age. Thus, regular clinical follow-ups, 
abdominal ultrasound studies and periodic liver function tests, as well as serological tests for viral hepatitis, are 
strongly recommended. These can help in the early detection of these complications and allow opportunities for 
their management and prevention.
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املنجلي،  الدم  فقر  امل�سابني مبر�ض  املر�سى  ال�سفراوية عند  الكبدية-  امل�ساعفات  لو�سف منط  الدرا�سة  تهدف هذه  الهدف:  امللخ�ص: 
ولتقييم مدى ترابطها مع العمر واجلن�ض وعوامل الختطار الأخرى. الطريقة: مت يف هذه الدرا�سة املقطعية تقييم 106 مري�سا بفقر الدم 
املنجلي اأدخلوا مل�ست�سفى الوحدة التعليمي يف عدن باليمن بني يناير و يونيو 2009م. وبعد اأخذ التاريخ املر�سي والفح�ض ال�سامل وعمل 
)والتي �سملت �سورة الدم الكاملة واختبارات وظائف الكبد وموؤ�رشات الإ�سابة بالفريو�سات( مت فح�ض  الفحو�ض املختربية ال�رشورية 
لتقييم مدى  ال�سفراوية  الكبدية-  للم�ساعفات  الإمرا�سية  ال�رشيرية  اخلوا�ض  املر�سى. ومت حتليل  لكل  ال�سوتية  فوق  باملوجات  البطن 
ترابطها بعوامل الختطار املختلفة كالعمر واجلن�ض. النتائج: وجد اأن نحو %46.2 من مر�سى فقر الدم املنجلي يف هذه الدرا�سة اأعرا�سا 
 26.0% اأعرا�ض مر�ض الكبد الفريو�سي، بينما كان عند نحو  من هوؤلء   36.7% – �سفراوية. واأظهر نحو  دالة على م�ساعفات كبدية 
وترواحت   .60.4% تبلغ  امل�سابني  املر�سى  بني  الذكور  ن�سبة  وكانت  التوايل.  على  �سفراوية،  وح�سوات  مرارة  التهاب  منهم  و20% 
متو�سطات ن�ساط انزميي ناقل اأمني الأللني وناقل اأمني ال�سبريتات بني 56.0 و 59.4 وحدة دولية و 38.3 و 40.1 وحدة دولية، على 
التوايل، وكانت ن�سبها اأعلى عند امل�سابني بالتهاب الكبد الفريو�سي و التهاب املرارة. واأظهرت م�ست�سدات ال�سطح يف فريو�ض التهاب الكبد 
الوبائي ب اإيجابية اأكرث )%10.4( من اأ�سداد التهاب الكبد الوبائي اأ و ج. ووجد اأن معدلت امل�ساعفات الكبدية- ال�سفراوية تزداد مع 
العمر، وكانت اأكرث حدوثا يف املر�سي الأكرث دخول للم�ست�سفى و / اأو الذين اأجريت لهم عمليات نقل دم ب�سورة متكررة. اخلال�صة: وجد 
العمر.  تقدم  املنجلي، وتزداد معدلت حدوثها مع  الدم  فقر  امل�سابني مبر�ض  الأطفال  �سائعة عند  ال�سفراوية  الكبدية-  امل�ساعفات  اأن 
وظائف  واختبارات  ال�سوتية  فوق  باملوجات  البطن  فح�ض  درا�سات  وعمل  دورية  ب�سورة  �رشيرا  املر�سى  هوؤلء  مبتابعة  فين�سح  ولذا 
الكبد وال�سريولوجيا للكشف عن التهاب الكبد الفريو�سي. وهذا من �ساأنه امل�ساعدة يف الكت�ساف املبكر عن هذه امل�ساعفات ويوفر فر�سا 
لعالجها والوقاية منها.
مفتاح الكلمات: مر�ض فقر الدم املنجلي؛ اجلهاز اله�سمي؛ ال�سبيل ال�سفراوي؛ الأطفال؛ اليمن. 
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Sickle cell disease (SCD) is an inherited blood disease characterised by chronic haemolytic anaemia. The frequency of the 
HbS gene in Yemen is estimated to be 0.04, with an 
expected birth incidence of 20/10,000 per year.1 SCD is 
a multisystem disease with a variable range and degree 
of complications. The hepatobiliary system is often 
involved in SCD complications and can be affected 
in various ways, ranging from benign liver function 
abnormalities to dramatic clinical crises marked by 
acute hepatic failure.2,3 The liver is frequently affected, 
with a complex pathophysiology involving interrelated 
causative factors such as haemolysis, iron overload, 
transfusion complications, sickling consequences, 
vaso-occlusion and cholelithiasis.4 Since the 1950s, 
it has been theorised that hepatitis may cause liver 
disease in SCD patients.5 The global prevalence of viral 
hepatitis is 30–40%, 2–8% and 1.45% for hepatitis A, B 
and C strains, respectively.6 A study by Al-Ghonaim 
et al. found that hepatitis virus A (HAV) is the most 
common cause of viral hepatitis among children in 
Saudi Arabia.7 Gallstones are a common complication 
of SCD and their development is closely related to 
the disease’s severity and the intensity of haemolysis. 
Gallstone prevalence often increases in SCD patients 
over the age of five years.8
To the best of the authors’ knowledge, no previous 
studies have been done to characterise hepatobiliary 
complications among SCD patients in Yemen. The Al 
Wahda Teaching Hospital, one of the major tertiary 
hospitals in Yemen, admits many SCD patients with 
varied complications, including hepatobiliary system 
diseases. However, treating physicians have at times 
not recognised these diseases and, consequently, they 
have been left undiagnosed. The main objectives of 
this study, therefore, were to highlight the different 
patterns of hepatobiliary complications in Yemeni 
patients with SCD and to assess the relationship with 
age, gender and other risk factors.
Methods 
This cross-sectional descriptive study was conducted 
between 1 January and 30 June 2009 at Al Wahda 
Teaching Hospital in Aden, Yemen. The inclusion 
criteria comprised children of both genders between 
the ages of six months and 14 years with SCD 
confirmed by haemoglobin (Hb) electrophoresis. 
Patients who did not have electrophoresis-confirmed 
SCD, those with combined haemoglobinopathies, 
those who had not completed the required 
investigations and those who had abandoned the 
treatment were excluded from the study.
The parents of the patients were instructed to 
fill out a predesigned questionnaire, which included 
questions on demographic characteristics, current 
medical information, past medical history and 
previous hospital admissions and blood transfusions. 
Following this, a thorough physical examination, 
specifically designed to assess signs of hepatobiliary 
system disease was carried out for each patient. 
All subjects underwent laboratory investigations to 
assess their Hb levels, white blood cell count, albumin, 
bilirubin (total and direct), alkaline phosphatase 
(ALP), alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST) levels. The normal ranges 
for these tests are indicated as follows: total bilirubin 
= 1.12 mg/dL; direct bilirubin = 0.6 mg/dL; ALT ≤12 
U/L; AST ≤14 U/L, and ALP ≥200 U/L. Serological 
tests for viral hepatitis were performed, using the 
enzyme-linked immunosorbent assay MAXMAT kit 
(MAXMAT S.A, Montpellier, France) to detect anti-
HAV antibodies, hepatitis B (HBV) surface antigen 
and anti-hepatitis C (HCV) antibodies.
An abdominal ultrasound was performed on 
all of the studied patients using a Doppler colour 
ultrasound machine with a 3.5 megahertz frequency. 
The patients were instructed to fast overnight and the 
ultrasound was conducted the following morning. 
Standard views were obtained in the transverse and 
sagittal plains with the subjects in supine, right lateral 
and left lateral decubitus positions. The ultrasound 
results were used to assess the standard features of 
SCD, such as the surface, edge and size of the liver; the 
echogenicity of the liver parenchyma; the dilatation of 
the bile ducts; the status of the pancreas; evidence of 
gallbladder disease, and other diagnostic features of 
disease processes, if they were present in the patient. 
Liver biopsies were not performed on the subjects due 
to the expense and time required. In suspected cases 
of salmonella, patients underwent stool and blood 
culture tests. Other investigations were carried out 
according to clinical indications. 
The data were processed and analysed using the 
Statistical Package for the Social Sciences (SPSS), 
Version 16.0 (IBM Corp., New York, USA). The 
statistical analysis included a quantitative descriptive 
analysis and summary statistics consisting of the mean, 
percentages and standard deviations with a confidence 
interval of 95%. The analysis was based on the Chi-
squared test, Fisher’s exact test, odds ratio, student-t 
test and univariate analysis of variance. A P value of 
<0.05 was considered statistically significant.    
This study was approved by the Ethical Committee 
at the Faculty of Medicine & Health Sciences of Aden 
University in Aden, Yemen. All of the patients’ parents 
gave permission for their inclusion in the study.
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Results
A total of 106 SCD patients were included in the 
study, of which 49 (46.2%) had hepatobiliary 
complications. The male to female ratio was 1.5:1 with 
SCD complications occurring more commonly in male 
patients (55.1%). The main complications reported 
were viral hepatitis (36.7%), cholecystitis (26.0%) and 
gallstones (20.0%). The prevalence of cholecystitis was 
substantially higher among the male patients, as 76.9% 
of those affected were male [Table 1]. 
There was a significant connection between age 
and the different forms of hepatobiliary complications 
[Table 1]. Of the patients with cholecystitis, 92.3% 
were found to be five years of age or older, while 44.4% 
of the patients with viral hepatitis were 5.1–10 years 
old. 
Of the patients who had previously been admitted 
to hospital more than 10 times (n = 20), six (30.0%) 
had cholecystitis, four (20.0%) had gallstones and 
three (15.0%) had biliary sludge. The frequency of 
blood transfusions among the patients was related 
to the varying forms of hepatobiliary complications 
[Table 2]. Of the patients who had previously had more 
than three blood transfusions, 62.5% presented with 
biliary sludge and 60% had gallstones. Hepatobiliary 
complications increased significantly with age and 
were notably higher among those who were often 
admitted to hospital and/or underwent frequent blood 
transfusions. 
The mean Hb levels of the patients with viral 
hepatitis, cholecystitis and gallstones were 5.3, 6.2 
and 6.0 g/L respectively. The mean total bilirubin 
and indirect bilirubin levels (9.5 and 7.1 mg/dL, 
respectively) were high in viral hepatitis cases, while 
the mean ALT (59.4 and 56.0 U/L) and AST (40.1 
and 38.3 U/L) levels were significantly higher in 
those patients with viral hepatitis and cholecystitis, 
respectively.
Discussion
The hepatobiliary tract of a patient with SCD may be 
affected by the disease in various ways. Of the 106 
patients observed in this study, 49 had hepatobiliary 
complications. A higher proportion of males were 
affected in comparison to female patients. Similar 
studies performed in Yemen by Bamahraz et al. and 
in Saudi Arabia by Mulik et al.9,10 also found a male 
predominance among their affected subjects. The 
authors of this study therefore theorise that male 
patients have a higher prevalence of hepatobiliary 
complications due to their greater exposure to 
certain precipitating factors of SCD crises. These 
factors include frequent infections as well as regular 
outdoor physical activities that may lead to an elevated 
metabolic process and increased sweating. This may 
cause some degree of dehydration, increased blood 
viscosity and increased oxygen consumption, leaving 
male patients more susceptible to developing SCD 
crises.11 
Table 1: Types of hepatobiliary complications by gender and 
age among patients with sickle cell disease (N = 49)












Male 8 (44.4) 10 (76.9) 5 (50.0) 4 (50.0)*





0 (0.0) 0 (0.0) 0 (0.0) 1 (12.5)†
2.1–5 
years
5 (27.8) 1 (7.7) 0 (0.0) 2 (25.0)†
5.1–10 
years
8 (44.4) 3 (23.1) 6 (60.0) 2 (25.0)‡
>10 years 5 (27.8) 9 (69.2) 4 (40.0) 3 (37.5)§
*Three patients with biliary sludge and one with periportal fibrosis; **Three 
patients with biliary sludge and one with liver cirrhosis; †One patient with 
biliary sludge; ‡One patient with biliary sludge and one with liver cirrhosis; 
§Two patients with biliary sludge and one with periportal fibrosis.
Table 2: Frequency of hospital admissions and blood 
transfusions among sickle cell disease patients with 
hepatobiliary complications (N = 49)











Frequency of previous hospital admissions
0 1 (5.6) 1 (7.7) 1 (10.0) 1 (12.5)*
1–3 6 (33.3) 5 (38.5) 3 (30.0) 1 
(12.5)**
4–9 7 (38.9) 1 (7.7) 2 (20.0) 3 (37.5)†
≥10 4 (22.2) 6 (46.2) 4 (40.0) 3 (37.5)*
Frequency of previous blood transfusions per year
0 1 (5.6) 2 (15.4) 1 (10.0) 1 (12.5)
1 3 (16.7) 2 (15.4) 1 (10.0) 1 (12.5)
2 4 (22.2) 2 (15.4) 2 (20.0) 1 (12.5)
≥3 10 (55.6) 7 (53.8) 6 (60.0) 5 (62.5)*
*One patient with biliary sludge; **One patient with periportal fibrosis; 
†Two patients with biliary sludge and one with liver cirrhosis.
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The results of this study also show that hepato-
biliary complications are significantly correlated to a 
patient’s age and the prevalence of such complications 
significantly increases in patients aged five years 
and older. In addition, it was observed that a higher 
proportion of patients with previous histories of 
hospital admissions and blood transfusions were more 
commonly affected by hepatobiliary complications, 
mainly viral hepatitis, cholecystitis and gallstones. 
This could be explained by the fact that patients 
who were exposed to a higher frequency of hospital 
admissions had a greater likelihood of presenting 
with frequent crises associated with haemolysis. 
This in turn likely increased their opportunity for 
further blood transfusions, raising the likelihood of 
gallstone formation. In addition, it is possible that the 
blood transfusions predisposed patients to acquiring 
viral hepatitis from infected blood. Hence, there is 
a connection between frequent blood transfusions, 
gallstone formation and viral hepatitis. The current 
study’s findings, with regards to the correlation 
between hospital admissions, blood transfusions 
and gallstone formation, were comparable to those 
reported in a study by Darko et al.12 A high proportion 
of the patients with hepatitis in the current study had 
had at least one previous blood transfusion and 5% had 
had at least three. This result was similar to findings 
noted by Ocak et al.13
Cholecystitis is considered one of the most 
common hepatobiliary complications in patients with 
SCD, often occurring due to a gallstone obstruction 
or infections. This complication was observed in 
approximately one-fifth of those with hepatobiliary 
complications in the current study, while similar 
results were found in a comparable study performed 
in India.14 It is likely that cholecystitis developed in the 
affected patients due to an infectious process. However, 
it may alternatively have been caused by an obstructive 
gallbladder stone, or as a hepatobiliary crisis due to the 
sickling process. In the current study, the frequency 
of developing cholecystitis increased with a patient’s 
age, as a high proportion of cholecystitis patients 
were over 10 years old. This could be explained by the 
fact that cholecystitis is largely attributed to gallstone 
formation, which requires time for development. 
There was also a higher prevalence of cholecystitis 
among the male subjects. This result is in contrast to 
a similar study performed in the Congo that did not 
see a gender difference in cholecystitis prevalence.15 
These opposing results may be due to the differences 
in the sample size, time frame and the methods used 
for cholecystitis detection between the studies.
Biliary sludge is one of the most intriguing 
complications of SCD.3 It is a mixture of calcium 
bilirubinate and cholesterol crystals found within 
viscous bile, containing a high concentration of 
mucus and proteins.16 In the current study, biliary 
sludge was found in nine patients (18.3%). This 
was similar to findings from a Saudi Arabian study 
(16.4%),10 but exceeded that of studies performed in 
the Congo (2.1%)15 and India (8%).14 These variations 
may have occurred because the sludge formation and 
evaporation is a dynamic process caused by frequent 
intermittent haemolysis, biliary tract infections and 
fluctuations in the inflammation levels which can 
differ from one SCD population to another.8 Patients 
with biliary sludge need regular follow-up as most 
are prone to gallstone formation. Therefore, regular 
examinations are important for the early prevention 
and proper management of predisposing factors.17
The formation of pigmented gallstones in SCD 
patients is the result of an excessive production of 
bilirubin due to red cell haemolysis. Its prevalence 
depends on age, gender and methods of detection, in 
addition to the patient’s geographical location and, 
in some cases, dietary habits.18 In this study, only a 
few patients were found to have gallstones (20.4%). A 
study performed in Western Orissa, India, had similar 
results.14 However, a study from Turkey reported a 
much higher prevalence,8 while studies from Yemen19 
and Ghana12 noted lower prevalences of 4.49% and 
4%, respectively. Several factors appear to cause these 
significant variations in the reported prevalence of 
gallstones, including the patient’s age, type of imaging 
equipment used and the standard and sophistication 
of this equipment.20 The reason for the comparatively 
low prevalence of gallstones among SCD patients in 
some areas is not clear. However, it may be related 
to the general low incidence of gallstones in some 
populations, such as certain African countries.12     
In this study, 22.4% of all subjects presented with 
HBV. This result may reflect the lack of necessary 
vaccinations available to individuals in Yemen. The 
authors recommend that Yemeni SCD patients 
undergo an annual screening for HBV and that patients 
with an HBV surface antibody titre of <10 should be 
revaccinated. 
The mean Hb values of patients with gallstones 
were not significantly different from those patients 
without gallstones; this result is consistent with a study 
by Sarnaik et al.21 White blood cell counts were high 
among patients who had gallstones and biliary sludge, 
which is similar to a study by Longo-Mbenza et al.15 
The majority of the current patients had elevated mean 
total bilirubin, direct bilirubin, AST, ALT and ALP 
levels, with a significant elevation of AST and ALT in 
those patients with viral hepatitis and cholecystitis. 
This is comparable with a study from Brazil.22
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Based on the results of the current study, the 
authors recommend that thorough family education 
and genetic counselling be offered to all those affected 
by SCD. In addition, the regular and continuous 
follow-up of patients with SCD should be emphasised. 
These follow-ups should include routine vaccinations, 
additional abdominal ultrasounds, periodic liver 
function tests, serological tests for viral hepatitis and 
serum ferritin level tests to help in the early diagnosis 
and management of common SCD complications.
Conclusion
Hepatobiliary complications in SCD patients are 
common and their prevalence increases as patients 
age, with the exception of gallstones which can 
occur from an early age. Among the group of studied 
patients, the most frequent complications were viral 
hepatitis, cholecystitis and gallstones. There was a 
strong correlation between the occurrence of these 
complications and the frequency of previous blood 
transfusions and hospital admissions. Based on 
the findings of this study, genetic counselling and 
education about the potential complications linked to 
this condition are recommended for SCD patients and 
their families. In addition, follow-up appointments 
and examinations must be prioritised in order to pre-
empt the development of SCD complications and to 
monitor existing symptoms.
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